Two pharmaceutical companies are eager to advance a different approach to treating lung cancer.
Clarient Launches New Gene Mutation Test for Lung Cancer
Clarient has launched a new gene mutation test to help physicians select the appropriate therapy for non-small cell lung cancer.
